MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A

Medical Oncology

Volumn 32, Issue 1, 2015, Pages 1-11

  Huang, Bin ^a   Xiao, Enhua ^a   Huang, Manping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Extracellular regulated kinase 1 2; Hypoxia; Mitogen extracellular kinase; Vasculogenic mimicry; VE cadherin

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; EPHRIN RECEPTOR A2; GELATINASE A; GELATINASE B; LAMININ; LAMININ GAMMA 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN EXTRACELLULAR KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HYPOXIA; LIVER CELL CARCINOMA; MOLECULAR MIMICRY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULOGENIC MIMICRY; ZYMOGRAPHY; BIOLOGICAL MIMICRY; CELL HYPOXIA; FLUORESCENT ANTIBODY TECHNIQUE; LIVER TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BIOLOGICAL MIMICRY; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84920152081     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0408-7     Document Type: Article

References (39)

1. Barinaga M. A face-off over tumor blood supply. Science. 2000;287(783):785.
2. Kudo M, Tochio H. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma. Oncology. 2008;75(Suppl 1):55–64.
3. Francescone R, Scully S, Bentley B, et al. Glioblastoma-derived tumor cells induce vasculogenic mimicry through flk-1 protein activation. J Biol Chem. 2012;287:24821–31.
4. Vartanian AA. Signaling pathways in tumor vasculogenic mimicry. Biochemistry. 2012;77:1044–55.
5. Sun T, Sun BC, Zhao XL, et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology. 2011;54:1690–706.
6. Sun T, Zhao N, Zhao XL, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51:545–56.
7. Li Y, Cai W, Yi Q, et al. Lipid droplets may lay a spacial foundation for vasculogenic mimicry formation in hepatocellular carcinoma. Med Hypotheses. 2014;83:56–9.
8. Liu WB, Xu GL, Jia WD, et al. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Med Oncol. 2011;28(Suppl 1):S228–38.
9. Wang LJ, Zhao Y, Han B, et al. Targeting slit-roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci. 2008;99:510–7.
10. Wen ZH, Su YC, Lai PL, et al. Critical role of arachidonic acid-activated mtor signaling in breast carcinogenesis and angiogenesis. Oncogene. 2013;32:160–70.
11. Ammirante M, Shalapour S, Kang Y, et al. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts. Proc Natl Acad Sci USA. 2014;111:14776–81.
12. Yoo YG, Christensen J, Gu J, et al. HIF-1α mediates tumor hypoxia to confer a perpetual mesenchymal phenotype for malignant progression. Sci Signal. 2011;4:pt4.
13. Du J, Sun B, Zhao X, et al. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecol Oncol. 2014;133:575–83.
14. Huang M, Ke Y, Sun X, et al. Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α. Oncol Rep. 2014;32:1973–80.
15. Sun B, Zhang D, Zhang S, et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett. 2007;249:188–97.
16. Toth M, Sohail A, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Biol. 2012;878:121–35.
17. Lin P, Wang W, Sun BC, et al. Vasculogenic mimicry is a key prognostic factor for laryngeal squamous cell carcinoma: a new pattern of blood supply. Chin Med J (Engl). 2012;125:3445–9.
18. Wang SY, Ke YQ, Lu GH, et al. Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma. J Neurooncol. 2013;112:339–45.
19. Du J, Xu R, Hu Z, et al. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells. PLoS One. 2011;6:e25213.
20. Kim JY, Kim YJ, Lee S, et al. The critical role of erk in death resistance and invasiveness of hypoxia-selected glioblastoma cells. BMC Cancer. 2009;9:27.
21. Lee SW, Won JY, Lee HY, et al. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Mol Med. 2011;17:1095–106.
22. Zhang JG, Li XY, Wang YZ, et al. Rock is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line. PLoS One. 2014;9:e107661.
23. Lu XS, Sun W, Ge CY, et al. Contribution of the PI3K/MMPS/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol. 2013;42:2103–15.
24. Chen LX, He YJ, Zhao SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther. 2011;11:229–35.
25. Hess AR, Seftor EA, Seftor RE, et al. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003;63:4757–62.
26. Minami M, Koyama T, Wakayama Y, et al. EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines. Mol Biol Cell. 2011;22:3508–19.
27. Lema Tome CM, Palma E, Ferluga S, et al. Structural and functional characterization of monomeric ephrina1 binding site to EphA2 receptor. J Biol Chem. 2012;287:14012–22.
28. Yu T, Wu Y, Helman JI, et al. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res. 2011;9:161–72.
29. Lakka SS, Jasti SL, Gondi C, et al. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene. 2002;21:5601–8.
30. Kim S, Choi JH, Lim HI, et al. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal. 2009;21:892–8.
31. Karroum A, Mirshahi P, Faussat AM, et al. Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions. Eur J Pharmacol. 2012;685:1–7.
32. Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol. 2004;25:1375–82.
33. Bachmann VA, Riml A, Huber RG, et al. Reciprocal regulation of PKA and Rac signaling. Proc Natl Acad Sci USA. 2013;110:8531–6.
34. Pettersson F, Couture MC, Hanna N, et al. Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK. Oncogene. 2004;23:7053–66.
35. Matsuoka H, Tsubaki M, Yamazoe Y, et al. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways. Exp Cell Res. 2009;315:2022–32.
36. Hirota Y, Tsukazaki T, Yonekura A, et al. Activation of specific MEK–ERK cascade is necessary for TGFβ signaling and crosstalk with PKA and PKC pathways in cultured rat articular chondrocytes. Osteoarthr Cartil. 2000;8:241–7.
37. Zeni AL, Zomkowski AD, Maraschin M, et al. Involvement of PKA, CaMKII, PKC, MAPK/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test. Pharmacol Biochem Behav. 2012;103:181–6.
38. Hu HJ, Gereau RWT. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. II. Modulation of neuronal excitability. J Neurophysiol. 2003;90:1680–8.
39. Lissitzky JC, Parriaux D, Ristorcelli E, et al. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res. 2009;69:802–9.